Burdwan Diagnostic & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.84 Cr
as on 14-12-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.96 Cr
as on 14-12-2024
- Satisfied Charges ₹ 5.98 Cr
as on 14-12-2024
- Revenue 5.21%
(FY 2023)
- Profit -48.77%
(FY 2023)
- Ebitda -49.09%
(FY 2023)
- Net Worth 3.15%
(FY 2023)
- Total Assets 13.44%
(FY 2023)
About Burdwan Diagnostic & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 1.84 Cr.
The company currently has active open charges totaling ₹3.96 Cr. The company has closed loans amounting to ₹5.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nandan Gupta, Jaya Pabi, Kushanava Pabi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110WB1995PTC072289
- Company No.
072289
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Burdwan Diagnostic & Research Centre?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandan Gupta  | Director | 30-Sep-2004 | Current |
| Jaya Pabi | Director | 20-Jun-2000 | Current |
| Kushanava Pabi | Director | 20-Jun-2000 | Current |
| Shreeya Pabi | Director | 20-Sep-2019 | Current |
| Ravi Kaushik | Director | 16-Nov-2020 | Current |
Financial Performance of Burdwan Diagnostic & Research Centre.
Burdwan Diagnostic & Research Centre Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 5.21% increase. The company also saw a substantial fall in profitability, with a 48.77% decrease in profit. The company's net worth moved up by a moderate rise of 3.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Burdwan Diagnostic & Research Centre?
In 2023, Burdwan Diagnostic & Research Centre had a public holding of 40.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Chittaranjan Pharma Private LimitedActive 10 years 10 months
Nandan Gupta and Kushanava Pabi are mutual person
- Vardhaman Mahaveer Medical College And Hospital Private LimitedActive 2 years 8 months
Nandan Gupta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Mar 2019 | ₹3.85 Cr | Open |
Ge Capital Services India Creation Date: 19 Jun 2007 | ₹1.10 M | Open |
Axis Bank Limited Creation Date: 31 May 2017 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Burdwan Diagnostic & Research Centre?
Unlock and access historical data on people associated with Burdwan Diagnostic & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Burdwan Diagnostic & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Burdwan Diagnostic & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
